Multi-Drug Resistance in Cancer (Hardcover)

Idioma: inglés

Editorial: John Wiley & Sons Inc, New York, 2023

1394209215 / 9781394209217

Librería: Grand Eagle Retail, Bensenville, IL, Estados Unidos de AmericaGrand Eagle Retail

Vendedor de 5 estrellas

Vendedor de IberLibro desde 12 de octubre de 2005

Tapa dura

Condición: Nuevo

EUR 187,31

 Gastos de envío gratis 
Se envía dentro de Estados Unidos de America

Cantidad disponible: 1 disponible

Añadir al carrito
Devoluciones gratuitas de 30 días

Descripción del artículo del vendedor

Hardcover. MULTI-DRUG RESISTANCE IN CANCER The book details the mechanisms underlying multi-drug cellular resistance and the targets of novel chemotherapeutic agents. Cancer is a major killer all over the world. Even with all the progress made, chemotherapy is still the mainstay of modern cancer treatment. The progression of the cellular defeat of numerous independent anticancer drugs in terms of their chemical structure is a major barrier to successful chemotherapy. Multi-drug resistance (MDR) is a term for the fact that most cancer patients exhibit this phenomenon. According to the numbers, drug resistance carries the blame for 90% of cancer patient deaths. Refractory cancer and tumor recurrence are common outcomes of prolonged chemotherapy. Because of the prevalence of drug-resistance mutations, the difficulty of treating tumors increases and the therapeutic efficacy of drugs decreases. Multi-Drug Resistance in Cancer: Mechanism and Treatment Strategies contains nine chapters that cover topics such as: studying the mechanics of resistance to drugs by autophagy; studies to delineate the role of efflux transporters; expression of drug transporters; resistance to targeted therapies in breast cancer; advances in metallodrug driven combination treatment for cancer; and use of natural agents for the overcoming of cancer drug resistance. The book aims to provide the latest data on the mechanisms of cellular resistance to anticancer agents currently used in clinical treatment. It provides a better understanding of the mechanisms of MDR and targets of novel chemotherapy agents which should guide future research concerning new effective strategies in cancer treatment. Audience This book is written for pharmaceutical and biomedical scientists and researchers at both the bench and in the clinic who are interested in the mechanisms and strategies for overcoming cancers multi-drug resistance. Shipping may be from multiple locations in the US or from the UK, depending on stock availability.…

N° de ref. del artículo 9781394209217

Título
Multi-Drug Resistance in Cancer (Hardcover)
Autor
Rishabha Malviya
Editorial
John Wiley & Sons Inc, New York
Año de publicación
2023
Estado
new
Encuadernación
Hardcover
Idioma
inglés
ISBN 10
1394209215
ISBN 13
9781394209217

Grand Eagle Retail

Bensenville, IL, Estados Unidos de America

Vendedor de 5 estrellas

Vendedor de IberLibro desde 12 de octubre de 2005

Tarifas de envío en Estados Unidos de America

ArtículoDe 6 a 14 días hábilesDe 6 a 16 días hábiles
Primer artículoEUR 0,00EUR 0,00
Los plazos de entrega los establecen los vendedores y varían según el transportista y la ubicación. Los pedidos que pasan por la aduana pueden sufrir retrasos y los compradores son responsables de los aranceles o tarifas asociadas. Los vendedores pueden ponerse en contacto con usted en relación con cargos adicionales para cubrir cualquier aumento en los costes de envío de los artículos.

Métodos de pago

  • Visa
  • Mastercard
  • American Express
  • Carte Bleue
  • Apple Pay
  • Google Pay

Información empresarial del vendedor

APOLLO ONLINE CORP.

605 Geddes Street
Wilmington, DE Estados Unidos de America 19805